Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 471 to 480

RIVAROXABAN DR.REDDY'S/RIVAROXABAN-REDDY'S/ RIVAROXABAN-DRLA/ RIVAROXABAN-RZ (Dr Reddys Laboratories Australia Pty Ltd)

9 May 2018

Prescription medicine registration

Active ingredients: Rivaroxaban.
TERRY WHITE CHEMISTS PANTOPRAZOLE HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

1 May 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DISCOUNT DRUG STORES FEXOFENADINE 180mg fexofenadine hydrochloride 180mg film coated tablet blister pack (new formulation) Cancelled under Section 30(1)(c) of the Act

1 May 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 2.5mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 5mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 10mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 20mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
BORTEZOMIB-REDDY'S; BORTEZOMIB-DRLA; BORTEZOMIB-RZ (Dr Reddys Laboratories Australia Pty Ltd)

8 March 2018

Prescription medicine registration

Active ingredients: Bortezomib.
Calcium GH Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY HEALTH CETIRIZINE cetirizine hydrochloride 10mg film coated tablet blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 44
Page 45
Page 46
Page 47
Current page 48
Page 49
Page 50
Page 51
Page 52
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.